0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biothreat Detection Market by Technology, Product Type, Application, End User - Global Forecast to 2030- Product Image
Biothreat Detection Market by Technology, Product Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Biothreat Detection Market by Technology, Product Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010911
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biothreat Detection Market grew from USD 17.48 billion in 2024 to USD 18.91 billion in 2025. It is expected to continue growing at a CAGR of 7.91%, reaching USD 27.60 billion by 2030.

Navigating the New Frontier of Biothreat Detection

The biothreat detection landscape has never been more critical as global health security faces evolving challenges from both natural and engineered pathogens. Recent incidents underscore the necessity for rapid, reliable, and field-deployable diagnostic tools that can differentiate harmless agents from those posing genuine biological threats. Stakeholders across government, healthcare, and research sectors demand integrated solutions capable of delivering actionable intelligence in real time, while navigating complex regulatory frameworks and supply chain constraints.

This executive summary synthesizes the pivotal factors reshaping the market, identifies transformative shifts in technology and policy, examines the implications of forthcoming United States tariffs in 2025, and presents deep-dive segmentation and regional analyses. Further, it highlights the competitive landscape, outlines actionable recommendations, and details the rigorous research methodology behind our findings. Designed for decision-makers and industry experts, this overview provides a clear roadmap for leveraging innovation, mitigating risks, and capitalizing on emerging opportunities in biothreat detection.

Emerging Forces Redefining Biothreat Detection

Technological breakthroughs are revolutionizing how biothreat agents are identified and quantified. Advances in digital polymerase chain reaction platforms now allow quantification of nucleic acid targets with unprecedented sensitivity, while isothermal amplification methods enable rapid, equipment-light diagnostics in field settings. Meanwhile, mass spectrometry has achieved higher resolution and faster throughput, supporting detailed proteomic profiling of pathogens. Microarray and sequencing technologies have likewise matured, facilitating comprehensive genomic surveillance and rapid strain differentiation.

Regulatory bodies are adapting to these innovations through streamlined approval pathways and emergency use authorizations that accelerate time to market without compromising safety. Public-private partnerships have surged, uniting defense laboratories, clinical institutions, and technology firms to standardize protocols and share critical data. These developments, in concert with enhanced AI-driven analytics for pattern recognition and anomaly detection, are shifting the market from reactive to proactive threat mitigation. As a result, stakeholders are positioned to anticipate outbreaks, optimize resource allocation, and strengthen global biosecurity networks.

Unpacking the Ripple Effects of 2025 US Tariffs on Biothreat Markets

The impending tariffs set by the United States in 2025 are poised to alter the cost structure of imported instruments, reagents, and consumables integral to biothreat detection workflows. Manufacturers and end users alike will confront higher input costs that may ripple through pricing models, potentially dampening adoption rates of cutting-edge platforms. In response, some instrument providers are evaluating regional production facilities to localize supply, while reagent suppliers are exploring alternative raw materials and contract manufacturing partnerships.

Consequently, strategic sourcing will become paramount, with organizations seeking to diversify supplier portfolios and negotiate long-term agreements that lock in favorable pricing. Collaboration between instrument makers and end users is likely to intensify as co-development arrangements aim to optimize protocols and reduce reagent volumes per assay. At the same time, service providers offering assay optimization and technical support will see increased demand as laboratories strive to maintain throughput under tighter budgetary constraints. Overall, the tariff environment will necessitate agile supply chain strategies and deeper stakeholder collaboration to sustain innovation and resilience.

Decoding Market Segmentation to Drive Targeted Innovation

The market’s technological segmentation reveals immunoassay platforms continuing to dominate due to their robustness and ease of integration into existing laboratory workflows. Mass spectrometry is gaining ground in advanced laboratories requiring high-resolution molecular characterization, while microarray solutions serve niche applications in multiplexed pathogen detection. Polymerase chain reaction methodologies, including digital PCR for absolute quantification and isothermal amplification for rapid, on-site analysis, are witnessing the fastest adoption among decentralized testing sites. Sequencing technologies remain pivotal for genomic surveillance and variant monitoring.

By product type, consumables such as assay kits and sample preparation materials represent a stable recurring revenue stream, whereas instruments-both benchtop and increasingly portable models-drive capital expenditure budgets. Reagents continue to underpin assay performance and offer opportunities for differentiation through proprietary chemistries. Services encompassing assay development, validation, and technical support have emerged as critical enablers for successful deployment, especially in resource-constrained settings. Applications span bioforensics and environmental monitoring, where high specificity is required, while clinical diagnostics leverages infectious disease testing and pathogen surveillance to inform patient care. Food testing laboratories, too, depend on sensitive detection methods to prevent outbreaks. End users range from defense and public health laboratories to private testing facilities, along with hospitals, clinics, and research institutes that integrate detection platforms into broader biosafety programs.

Regional Variations Shaping Global Biothreat Responses

The Americas continue to lead in R&D investment and regulatory modernization, supported by extensive government funding for biosecurity initiatives. North American laboratories prioritize integration of automated workflows and digital reporting, aiming to shorten response times to potential threats. Latin American nations are enhancing their laboratory networks and forging cross-border collaborations to improve regional surveillance capabilities.

In Europe, Middle East, and Africa, stringent regulations and harmonization across member states are driving standardization of diagnostic protocols. The European Union’s emphasis on joint procurement and shared data platforms fosters collective preparedness, while emerging markets in the Middle East and Africa focus on building basic laboratory infrastructure and training skilled personnel. Asia-Pacific markets are characterized by rapid adoption of portable instruments and mobile diagnostics, underpinned by significant investments in genomic research and pandemic preparedness programs. China, Japan, and Australia spearhead innovation, while Southeast Asian countries expand their environmental monitoring networks to address zoonotic risks.

Competitive Dynamics Illuminating Industry Leaders

Major players in the biothreat detection arena are expanding their portfolios through strategic acquisitions and partnerships. Thermo Fisher Scientific leverages its global distribution network and broad product range to offer integrated solutions from sample preparation through data analysis. Bio-Rad Laboratories focuses on digital PCR innovation, delivering high-precision quantification platforms tailored for critical research and diagnostic applications. Illumina drives sequencing excellence with its next-generation platforms, enabling comprehensive genomic surveillance of evolving pathogens.

Meanwhile, QIAGEN and Roche Diagnostics emphasize streamlined workflow kits paired with digital reporting portals, aiming to reduce hands-on time and simplify data interpretation. Agilent Technologies and PerkinElmer enhance mass spectrometry and microarray capabilities for specialized bioforensics and environmental monitoring. Danaher’s Beckman Coulter division and Merck’s MilliporeSigma business invest in reagent optimization and modular instrumentation to meet the needs of decentralized testing environments. Service-based providers are carving out niches in assay validation, regulatory compliance, and field deployment support, creating collaborative ecosystems that accelerate technology adoption and drive customer success.

Strategic Imperatives for Biothreat Detection Stakeholders

Leaders should prioritize development of modular platforms that support both central laboratory and point-of-need testing, enabling seamless scalability in response to evolving threats. Investing in artificial intelligence-driven analytics will enhance real-time interpretation of complex datasets, allowing faster differentiation between benign and malicious agents. Diversifying manufacturing footprint across multiple regions can mitigate tariff impacts and supply disruptions, ensuring continuity of critical reagent and instrument availability.

Strengthening partnerships with defense laboratories, public health agencies, and academic institutions will foster knowledge exchange and drive standardized protocols, reducing time-to-result and improving data comparability. Organizations must also expand training and support services to empower end users with the skills required for optimal platform performance. Finally, integrating environmental and clinical data streams will provide a holistic view of pathogen dynamics, informing proactive containment strategies and enhancing overall biosecurity.

Rigorous Research Methodology Underpinning the Analysis

This analysis combines primary interviews with leading scientists, laboratory directors, and regulatory experts, alongside exhaustive secondary research covering peer-reviewed journals, patent filings, and government reports. Market dynamics have been validated through direct engagement with instrument manufacturers, reagent suppliers, and service providers to ensure alignment with real-world applications. Segmentation and regional frameworks were developed using a top-down approach, grounded in technology capabilities, product portfolios, application requirements, and end user profiles.

Data triangulation involved cross-referencing financial disclosures, procurement databases, and expert insights to confirm trends and identify emerging opportunities. Forecast accuracy was enhanced by stress-testing scenarios related to supply chain disruptions, regulatory changes, and evolving threat landscapes. Rigorous peer review by subject-matter specialists ensured that findings are both actionable and reflective of the latest industry developments.

Synthesis of Insights and Future Outlook

This executive summary synthesizes the central themes shaping biothreat detection’s future: the rise of high-sensitivity molecular tools, the imperative for supply chain resilience, and the strategic value of collaborative networks. We have examined how technological innovations intersect with regulatory evolution and emerging tariff regimes to create both challenges and openings for market participants. Segmentation insights clarify where to focus R&D and commercialization efforts, while regional analysis highlights localized priorities and investment trends.

By mapping competitive dynamics and distilling actionable recommendations, this overview provides a clear pathway for stakeholders to enhance readiness and capitalize on growth areas. Ultimately, robust biothreat detection capabilities are essential to safeguard public health, national security, and economic stability. The insights presented herein equip decision-makers with the knowledge required to navigate complexities and deliver meaningful impact in the face of evolving biological threats.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Immunoassay
    • Mass Spectrometry
    • Microarray
    • Polymerase Chain Reaction
      • Digital Polymerase Chain Reaction
      • Isothermal Amplification
    • Sequencing
  • Product Type
    • Consumables
    • Instruments
      • Benchtop Instruments
      • Portable Instruments
    • Reagents
    • Services
  • Application
    • Bioforensics
    • Clinical Diagnostics
      • Infectious Disease Testing
      • Pathogen Monitoring
    • Environmental Monitoring
    • Food Testing
  • End User
    • Government Laboratories
      • Defense Laboratories
      • Private Laboratories
      • Public Health Laboratories
    • Hospitals And Clinics
    • Research Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • bioMérieux SA
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Bruker Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biothreat Detection Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.3. Mass Spectrometry
8.4. Microarray
8.5. Polymerase Chain Reaction
8.5.1. Digital Polymerase Chain Reaction
8.5.2. Isothermal Amplification
8.6. Sequencing
9. Biothreat Detection Market, by Product Type
9.1. Introduction
9.2. Consumables
9.3. Instruments
9.3.1. Benchtop Instruments
9.3.2. Portable Instruments
9.4. Reagents
9.5. Services
10. Biothreat Detection Market, by Application
10.1. Introduction
10.2. Bioforensics
10.3. Clinical Diagnostics
10.3.1. Infectious Disease Testing
10.3.2. Pathogen Monitoring
10.4. Environmental Monitoring
10.5. Food Testing
11. Biothreat Detection Market, by End User
11.1. Introduction
11.2. Government Laboratories
11.2.1. Defense Laboratories
11.2.2. Private Laboratories
11.2.3. Public Health Laboratories
11.3. Hospitals And Clinics
11.4. Research Institutes
12. Americas Biothreat Detection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biothreat Detection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biothreat Detection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. F. Hoffmann-La Roche Ltd
15.3.4. QIAGEN N.V.
15.3.5. bioMérieux SA
15.3.6. Abbott Laboratories
15.3.7. Becton, Dickinson and Company
15.3.8. PerkinElmer, Inc.
15.3.9. Agilent Technologies, Inc.
15.3.10. Bruker Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOTHREAT DETECTION MARKET MULTI-CURRENCY
FIGURE 2. BIOTHREAT DETECTION MARKET MULTI-LANGUAGE
FIGURE 3. BIOTHREAT DETECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOTHREAT DETECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOTHREAT DETECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOTHREAT DETECTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOTHREAT DETECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOTHREAT DETECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY BIOFORENSICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY PATHOGEN MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY FOOD TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY DEFENSE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY PRIVATE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOTHREAT DETECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOTHREAT DETECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. CANADA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 59. CANADA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. CANADA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. CANADA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 106. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 108. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 114. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 130. ITALY BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ITALY BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 132. ITALY BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. ITALY BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 136. ITALY BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ITALY BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 138. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 140. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SPAIN BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 170. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 172. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. DENMARK BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 186. QATAR BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. QATAR BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 188. QATAR BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. QATAR BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. QATAR BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. QATAR BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. QATAR BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. FINLAND BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. EGYPT BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 232. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TURKEY BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. NORWAY BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 250. POLAND BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. POLAND BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 252. POLAND BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 254. POLAND BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. POLAND BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 256. POLAND BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. POLAND BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC BIOTHREAT DETECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. CHINA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 277. CHINA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. CHINA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. CHINA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. CHINA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. CHINA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. CHINA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 283. INDIA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. INDIA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 285. INDIA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. INDIA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 287. INDIA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. INDIA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. INDIA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. INDIA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. JAPAN BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 323. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 325. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 327. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 329. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. THAILAND BIOTHREAT DETECTION MARKET SIZE, BY GOVERNMENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES BIOTHREAT DETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES BIOTHREAT DETECTION MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES BIOTHREAT DETECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES BIOTHREAT DETECTION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES BIOTHREAT DETECTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES BIOTHREAT

Companies Mentioned

The companies profiled in this Biothreat Detection market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • bioMérieux SA
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Bruker Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.91 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.6 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biodefense Market Report 2025 - Product Image

Biodefense Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Biosecurity and Bioterrorism. Containing and Preventing Biological Threats. Edition No. 2 - Product Image

Biosecurity and Bioterrorism. Containing and Preventing Biological Threats. Edition No. 2

  • Book
EUR$97USDGBP
Genomics in Biosecurity. Principles and Applications of Genomic Technologies in Expanded Biosecurity Concepts. Translational and Applied Genomics - Product Image

Genomics in Biosecurity. Principles and Applications of Genomic Technologies in Expanded Biosecurity Concepts. Translational and Applied Genomics

  • Book
EUR$154USDGBP
Biodefense - A Global Market Overview - Product Image

Biodefense - A Global Market Overview

  • Report
  • 255 Pages
  • Global
From
EUR$4,500USDGBP
Biodefense Market by Product Type, Application, End User, Distribution Channel, Pathogen Type - Global Forecast to 2030 - Product Image

Biodefense Market by Product Type, Application, End User, Distribution Channel, Pathogen Type - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.